Event Capital Strategies

Event Capital Strategies

Event Capital Strategies operates out of New York as a healthcare-focused private equity firm. Managing partners Richard Fay and Christopher Yamamoto each bring over two decades of experience in private equity and operating roles across healthcare, industrials, and medical technology. The firm was founded on the premise that a significant opportunity exists to displace incumbents in consolidated healthcare markets through technology and business-model innovation. The firm's investment strategy is thematic and exclusively targets large, addressable healthcare sub-sectors. It pursues buyouts in medication management, orthopedics, life sciences, diagnostics, and healthcare IT and services. Event Capital's approach relies on a dedicated team of operating partners — including a medical device CEO, a pharmaceutical CFO, a physician and institutional healthcare investor, and a contract manufacturing executive — who provide hands-on strategic support, stand in as interim management when needed, and accelerate the integration of carveouts and add-on acquisitions. The firm says it derives returns from fundamental operational, managerial, and financial improvements made during the ownership period. Event Capital’s investment team is led by Fay, Yamamoto, and Howard Jaslow, who has over 15 years of experience in private equity and healthcare M&A. The operating-partner bench includes Bob Roda (a medical device CEO), Gary Gemignani (a pharmaceutical CFO), Dr. Mohamad Hamade (a hospital chairman and Middle East institutional healthcare investor), and Tony Borowicz (a medical device contract manufacturing executive). The firm maintains a single office in New York and invests across the United States. Event Capital’s structural differentiator is its embedded operating-partner model: the firm staffs platform investments with a roster of executives who have led pharmaceutical and medical-device businesses, providing immediate operational bandwidth that is uncommon for a firm of its size. This team is designed to stand up carveouts rapidly and to fill management gaps directly, blurring the line between investor and interim operator.